ResearcherHarvard UniversityNo recent work listed
Mingfeng Zhang
Matched on ORCID iD 0000-0002-0138-3934; OpenAlex author ID A5072036320. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2016: 3 papers · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper
Papers 8
- A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
- Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
- Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-19-0577↗
- Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
- Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2016-312510↗
- Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression. Co-author DOI 10.1093/hmg/ddw300↗
- Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. Co-author DOI 10.1093/jnci/djv409↗
- Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brian Matthew Wolpin · 4 shared papers, 2016–2019 · strength 0.20
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-spec… DOI 10.1093/hmg/ddw300↗
- Laufey Thora Amundadottir · 4 shared papers, 2016–2019 · strength 0.20
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-spec… DOI 10.1093/hmg/ddw300↗
- Chen Yuan · 3 shared papers, 2016–2019 · strength 0.16
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Edward L. Giovannucci · 3 shared papers, 2016–2019 · strength 0.16
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- JoAnn E. Manson · 3 shared papers, 2016–2019 · strength 0.16
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Kimmie Ng · 3 shared papers, 2016–2019 · strength 0.16
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Peter Kraft · 3 shared papers, 2016–2019 · strength 0.16
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Charles S. Fuchs · 3 shared papers, 2016–2019 · strength 0.16
- Paper Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. DOI 10.1158/1055-9965.epi-19-0577↗
- Paper Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. DOI 10.1136/gutjnl-2016-312510↗
- Paper Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. DOI 10.1093/jnci/djv409↗
- Ana Babić · 2 shared papers, 2017–2019 · strength 0.12
- Thomas E. Rohan · 2 shared papers, 2017–2019 · strength 0.12
- Vicente Morales‐Oyarvide · 2 shared papers, 2017–2019 · strength 0.12
- Ying Bao · 2 shared papers, 2017–2019 · strength 0.12
- Zhi Rong Qian · 2 shared papers, 2016–2017 · strength 0.09
- Tsuyoshi Hamada · 1 shared paper, 2019 · strength 0.07
- Jonathan Andrew Nowak · 1 shared paper, 2019 · strength 0.07
- Natalia I. Khalaf · 1 shared paper, 2019 · strength 0.07
- Sara H. Olson · 1 shared paper, 2016 · strength 0.04
- Jason W. Hoskins · 1 shared paper, 2016 · strength 0.04
- Jill Palmer Smith · 1 shared paper, 2016 · strength 0.04
- Douglas Adam Rubinson · 1 shared paper, 2016 · strength 0.04
- Jared R. Mayers · 1 shared paper, 2016 · strength 0.04
- Hemang M. Parikh · 1 shared paper, 2016 · strength 0.04
- Jinping Jia · 1 shared paper, 2016 · strength 0.04
- Chen Hsuan Wu · 1 shared paper, 2016 · strength 0.04
- Rachael Z. Stolzenberg‐Solomon · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.